Total hip replacement: a retrospective multicentric analysis on re-intervention rate after single component revision.


Journal

Journal of biological regulators and homeostatic agents
ISSN: 0393-974X
Titre abrégé: J Biol Regul Homeost Agents
Pays: Italy
ID NLM: 8809253

Informations de publication

Date de publication:
Historique:
entrez: 2 12 2020
pubmed: 3 12 2020
medline: 29 1 2021
Statut: ppublish

Résumé

Total hip arthroplasty (THA) revision is a procedure consisting in the replacement of a single or multiple implant components and could take place once or more times (re-revision). The aim of this multicentre study is to evaluate the benefits of single component revision in respect of the principles that define implant stability. Two hundred and forty-two patients underwent THA revision at Orthopaedic Clinic of Pisa and Versilia (ITA) from January 2007 to December 2016. We have systematically excluded revisions due to septic or traumatic prosthesis loosening, revisions of both implant components (cotyle and stem) and replacement alone. To evaluate implant stability, we used preoperative X ray and intra-operative mechanical stress tests, applying accredited criteria. Two hundred and twenty-six patients (93%) underwent a single procedure of THA revision: 193 had cotyle replacement and 33 had femoral stem replacement. The remaining 16 (7 %) underwent at least two procedures: 10 of them had consecutive failure of the same component, while the other 6 had revision of the other component after the first procedure. Considering our cases series, we can assert that single component revision is the best choice when no signs of loosening are present on the remaining component. Nevertheless, an accurate evaluation with unanimous radiological criteria and intraoperative testing is essential for the surgeon to choose the most suitable treatment.

Identifiants

pubmed: 33261276
pii: 27

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

191-196. Congress of the Italian Orthopaedic Research Society

Informations de copyright

Copyright 2020 Biolife Sas. www.biolifesas.org.

Auteurs

F Cosseddu (F)

2nd Orthopedic Division University of Pisa, Italy.

S Shytaj (S)

2nd Orthopedic Division University of Pisa, Italy.

F Sacchetti (F)

1st Orthopedic Division University di Pisa, Italy.

R Capanna (R)

2nd Orthopedic Division University of Pisa, Italy.

M Manca (M)

Orthopedic Division, Versilia Hospital, Lido di Camaiore (LU), Italy.

P D Parchi (PD)

1st Orthopedic Division University di Pisa, Italy.

M Scaglione (M)

1st Orthopedic Division University di Pisa, Italy.

L Andreani (L)

2nd Orthopedic Division University of Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH